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Survivin inhibits excessive autophagy in cancer cells but does so
independently of its interaction with LC3
Nicola J. Humphry and Sally P. Wheatley*
ABSTRACT
Survivin expression is pivotal to life and death at the cellular level. For
the past decade its pro-survival activity has been attributed to its
essential role in cell proliferation and its ability to inhibit apoptosis.
However, a growing body of evidence suggests that it may also
contribute to cell viability through an as yet undefined role in
autophagy. We report that survivin overexpression in osteosarcoma
(U2OS) cells is associated with increased LC3-II expression, smaller
autophagosomes, enlarged lysosomes and reduced autophagic flux.
We also demonstrate that survivin binds LC3 directly through a
canonical LC3-interacting region (LIR) in its baculovirus inhibitors of
apoptosis protein (IAP) repeat BIR domain, mutation of which inhibits
the interaction, but does not abrogate its influence on autophagy.
Collectively these data suggest that survivin expression restricts
autophagic flux, thereby inhibiting late-stage autophagy and
preventing cell death, but does so independently of LC3.
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INTRODUCTION
Implicit in its name survivin is a protein that promotes cell survival. It
is overexpressed in cancer (Ambrosini et al., 1997) where its presence
correlates with increased resistance to chemotherapy (Paik et al.,
2004) and irradiation (Colnaghi et al., 2006), treatments aimed at
killing cancer cells. Thus its expression is a biomarker of poor patient
prognosis and survivin itself is a promising target for cancer therapy.
Survivin is both essential for mitosis and can suppress cell death
(Altieri, 2008; Wheatley and McNeish, 2005). It has a baculovirus
inhibitors of apoptosis protein (IAP) repeat (BIR) domain that
assigns it membership to the IAP family. Although expression of
survivin is cytoprotective (Ambrosini et al., 1997), and its depletion
increases apoptosis (Li et al., 1999; Ambrosini et al., 1998), the
exact mechanism by which it inhibits cell death remains uncertain.
In terms of apoptotic inhibition, several models have been
suggested, including inhibition of the mitochondrial apoptosis
promoting factor Smac/DIABLO (Pavlyukov et al., 2011; Song
et al., 2003); stabilization of X-linked inhibitor of pro-apoptotic
protein (XIAP) (Dohi et al., 2004); and induction of the
mitochondrial-nuclear translocation of apoptosis inducing factor
(Ambrosini et al., 1997).
Recently, several lines of evidence have suggested that survivin
may aid the evasion of cell death in ways distinct from apoptosis, one
of which is manipulation of autophagy, a catabolic process in which
intracellular components are broken down and re-used. Briefly,
autophagy targets specific intracellular components for degradation
by encasing them in a double-membraned vesicle, called an
‘autophagosome’ that is rich in the human Atg8 homologue,
microtubule-associated protein light chain 3 (MAP-LC3 or LC3)
bound to phosphatidylethanolamine (PE), LC3-II (Kabeya et al.,
2000). Autophagosomes can fuse with endosomes to form
amphisomes before fusing either transiently, or completely, with a
lysosome to form an autolysosome (Jahreiss et al., 2008). The
autophagosome contents are degraded by hydrolytic enzymes that
favour an acidic environment before the sub-components are released
back into the cytoplasm. Nascent lysosomes can reform from the
autolysosome by a process of budding termed ‘autophagic lysosome
reformation’ (ALR) (Yu et al., 2010). Basal levels of autophagy are
required for cellular homeostasis but, under stress, including radiation
treatment, autophagy is induced to promote cell survival. However,
intracellular re-cycling cannot continue ad infinitum and excessive
autophagy ultimately results in cell death (Maiuri et al., 2007).
Emerging data point to several aspects of autophagy that
may involve survivin. Firstly, it co-immunoprecipitates with the
key autophagic protein, LC3B (Roca et al., 2008); secondly, its
expression is upregulated by the autophagic suppressor, mTOR,
within the PI3K/Akt pathway (Roca et al., 2008; Zhao et al., 2010);
and finally, it interacts with the autophagic regulators Beclin 1 (Niu
et al., 2010) and Atg5 (Maskey et al., 2013). Using live fluorescence
imaging, immunoblotting and immunoprecipitation assays, here we
report that overexpression of survivin increases LC3-II levels,
reduces autophagosome size, enlarges lysosomes, and causes an
overall reduction in autophagic flux. We also show that expressing a
mutant version, survivinF61AL64A, that cannot bind to LC3, yields
similar outcomes. Thus, in addition to its roles in mitosis and
apoptosis, we show that survivin can also act in a pro-survival
manner by preventing excessive autophagy, but it does so
independently of its interaction with LC3.
RESULTS AND DISCUSSION
When survivin is overexpressed in cancer it is hugely detrimental to
human health: its abundance correlates with tumour resistance to
radiation, and this is recapitulated in cell culture (Colnaghi et al.,
2006; Connell et al., 2008; Chakravarti et al., 2004). X-irradiation
kills cells by inducing DNA damage and apoptosis, but it also
promotes autophagy (Jin et al., 2015; Chen et al., 2015). Therefore
we hypothesised that survivin may also protect cells against death
by limiting excessive autophagy.
Survivin reduces autophagic flux
To understand how survivin affects autophagy, we first measured
the level of LC3-II in U2OS cells overexpressing survivin with andReceived 26 July 2018; Accepted 23 August 2018
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without chloroquine (CQ). CQ is commonly used to assess
autophagic flux (Klionsky et al., 2016): it inhibits late stage
autophagy causing accumulation of autophagosomes. High LC3-II
levels suggest either increased autophagic flux or inhibition of late-
stage autophagy. CQ can help discriminate between these two
alternatives as it freely diffuses into lysosomes, but gets trapped
there where it inhibits degradative enzymes (Solomon and Lee,
2009; Kunze et al., 1982). If flux is increased CQ will further
increase LC3-II levels, however, if late-stage autophagy has been
inhibited, no difference will be seen (Klionsky et al., 2016). The use
of rapamycin (RAP) in combination with CQ allows us to study
autophagic flux above basal levels.
To investigate any potential effects that survivin has on
autophagy we chose to use U2OS cells stably expressing
survivinWTGFP (green fluorescent protein) or GFP (control).
These were treated simultaneously with RAP and/or CQ for 2 h,
and LC3II abundance quantified by immunoblotting of whole cell
lysates (Fig. 1A). Basal levels of LC3-II in survivinWTGFP cells
were significantly higher than in control cells (Fig. 1B). LC3II
levels also appeared higher in survivinWTGFP cells after treatment
with CQ, RAP or RAP/CQ, however, this did not achieve statistical
significance in a Student’s t-test. To determine whether this was due
to induction or inhibition of autophagic flux, we plotted the increase
in LC3II signal (Fig. 1C) and found that the increase was similar in
both GFP and survivinWTGFP cells, thus we concluded that
survivin inhibits flux, possibly in the same manner as CQ.
To confirm this finding, we assayed p62 levels in these cells. p62
is an adaptor protein that facilitates autophagic degradation by
binding to ubiquitinated targets in the cytosol, and to LC3-II
on the autophagosome. As a result, p62 itself is degraded by
autophagy and this phenomenon can be used to monitor autophagic
flux (Klionsky et al., 2016). U2OS cells stably expressing
survivinWTGFP or GFP were treated with CQ and p62 expression
was assessed at regular intervals from 0-8 h by immunoblotting. In
this experiment p62 accumulated significantly more slowly in
cells expressing survivin than in control cells, supported by linear
regression analysis of treated cell lines (P<0.0001; Fig. 1D,E),
further substantiating the hypothesis that survivin reduces
autophagic flux.
Survivin decreases the size of LC3-positive puncta
To investigate whether survivin alters the number or size of
autophagosomes, we measured these parameters in LC3-positive
puncta within the cell before and after RAP/CQ treatment. U2OS
cells transiently expressing GFP-LC3 and either red fluorescent
protein (RFP) or survivin-RFP were imaged live. RAP/CQ
treatment caused an increase in the size of LC3-puncta in both
RFP and survivin-RFP expressing cells, but those in cells
expressing survivin-RFP were significantly smaller (Fig. 2A,B).
The number of autophagosomes was similar in both conditions and
increased approximately twofold after RAP/CQ treatment (Fig.
S1A). These results suggest that survivin regulates autophagosome
maturation, potentially by inhibiting fusion with endosomes
(Huotari and Helenius, 2011; Eskelinen, 2005).
Survivin increases the size of acidic puncta
Fusion of the autophagosome with lysosomes creates an
autolysosome with an acidic lumen, allowing lysosomal proteases
to digest autophagosomal cell debris. To investigate whether
survivin has an impact on lysosomes and autolysosomes, we
measured the size and number of acidic puncta within the cell using
the cell permeable fluorescent dye, LysoTracker Red, which
accumulates in acidic compartments and thus highlights
lysosomes and autolysosomes.
To observe the difference in acidic compartments before and after
CQ inhibition, U2OS cells stably expressing survivinWTGFP or
GFP (control) were treated with CQ for 2 h and imaged live using
fluorescent microscopy. In both cell sub-lines, CQ treatment
increased the average size of acidic puncta, suggesting an
accumulation of autolysosomes and a concurrent reduction in
nascent lysosomes formation (Fig. 2C,D). Cells expressing
survivinWTGFP had significantly larger acidic puncta both pre-
and post-treatment compared to cells expressing GFP (Fig. 2C,D).
No significant difference in the number of acidic puncta between the
sub-lines was observed (Fig. S1B), suggesting that like CQ,
survivin causes an accumulation of autolysosomes and a concurrent
reduction in nascent lysosomes formation. However, since effects
were cumulative when survivin overexpression and CQ treatment
were combined, this suggests that survivin operates in a different
pathway from CQ.
One potential mechanism by which survivin could work is by
inhibiting autophagosome-lysosome fusion, as this causes an
increase in lysosome (acidic puncta) size (Chen, 2011).
Alternatively it may regulate ALR, a process that is triggered by
the reactivation of mTOR at the end of the autophagic pathway,
which involves the budding of proto-lysosomes from the
autolysosome, which then acquire lysosomal hydrolases and
mature into lysosomes (Yu et al., 2010). Inhibition of ALR would
decrease the number of small, nascent autolysosomes resulting in an
increase in mean lysosome size, similar to our observations in
survivin-expressing cells.
Survivin interactsdirectlywith LC3via aconservedLIR in the
BIR domain
Having established that survivin suppresses autophagic flux,
restricts the size of LC3 puncta and increases the size of acidic
puncta, we next asked whether this inhibition was due to association
with LC3, with which it is known to co-immunoprecipitate (Roca
et al., 2008).
The binding of proteins to LC3 usually occurs via canonical LC3
interaction regions (LIR), which are defined as tetrapeptides with an
aromatic residue at position one, and a hydrophobic residue at
position four: W/F/Y×X L/I/V (where X is any residue) (Noda et al.,
2008). Sequence analysis using iLIR (http://repeat.biol.ucy.ac.cy/
iLIR/) revealed that survivin has five putative LIR motifs, which are
highlighted in the primary sequence and the crystal structure
(Fig. 3A,B). The first three of these sequences are located within the
BIR domain; the fourth in the central linker between residues 90 and
98; and the fifth at the start of the C-terminal alpha helix. Regression
analysis of FASTA alignments (CLUSTAL W2, 10 iterations) of
survivin homologues from several mammals (EMBL-EBI: www.
ebi.ac.uk), was used to generate a sequence logo using (http://
weblogo.berkeley.edu) which showed that all five sites are highly
conserved (Fig. 3A). However, since functional LIRs are more
frequently associated with exposed beta strands (Noda et al., 2010),
we next looked at the position of these five sites in relation to beta
strands using UniProt (https://www.uniprot.org/). This stratagem
revealed that only F61KEL within the BIR domain conforms to this
rule, which is highlighted in the blue ribbon (Fig. 3B). Thus we
hypothesized that F61KEL was a bona fide LIR.
To test this hypothesis, we generated a mutant in which residues
at positions one and four of the putative LIR, F61KEL, were mutated
to an alanine, survivinF61A,L64A, tagged with either GFP, RFP or
flag, and the immunoprecipitation and fluorescence experiments
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were repeated. Unlike survivinWT, survivinF61A,L64A does not
associate with LC3 in either an immunoprecipitation of flag-
survivin or an immunoprecipitation of GFP-LC3, clearly
demonstrating that this is a functional and unique LIR in survivin
(Fig. 3A,B). However, expression of survivinF61A,L64A had the same
effect as the wild-type protein on LC3 puncta and acidic puncta size
suggesting that interaction with LC3 is not required for these
phenomena (Fig. 3E,F; see representative images in Fig. S1-C).
Consistent with this we also noted that there was no significant
co-localisation of survivin at LC3-positive puncta suggesting that
survivin does not accumulate on the membranes or in the lumen of
autophagosomes (data not shown).
Fig. 1. Survivin regulates autophagic flux. (A) U2OS cells stably expressing survivinWTGFP or GFP alone were treated with RAP (200 nM) and CQ
(120 µM) for 2 h, then lysed and immunoblotted with anti-LC3, anti-survivin and anti-tubulin antibodies. Immunoblot shown is representative of four
independent experiments. (B) ImageJ quantitation of LC3II signals in (A), normalised against tubulin control and expressed as band intensity relative to
untreated GFP cells. (C) Data from (B) expressed as a percentage increase in LC3II between CQ treated and untreated cells to indicate autophagic flux.
(D) The above cell lines were treated with CQ (50 µM) for 8 h and p62 levels assessed by immunoblotting at 2 h intervals. Blot shown is representative of
three independent experiments. (E) ImageJ quantitation of p62 signals in (D) normalised against tubulin and expressed as band intensity relative to untreated
GFP cells. Error bars indicate s.e.m., N=3. *P<0.05.
3
RESEARCH ARTICLE Biology Open (2018) 7, bio037374. doi:10.1242/bio.037374
B
io
lo
g
y
O
p
en
 by guest on December 10, 2018http://bio.biologists.org/Downloaded from 
Collectively these data demonstrate that survivin inhibits
autophagic flux through a mechanism that restricts
autophagosome size but it does so independently of its interaction
with LC3 and in a manner distinct from CQ. In addition to LC3,
survivin interacts with two other proteins involved in
autophagosome formation; Beclin 1 (Niu et al., 2010), which is
involved in membrane trafficking and localizing autophagic
proteins to the phagophore (Kang et al., 2011); and atg5 (Maskey
et al., 2013) which extends the phagophore and facilitates LC3
lipidation. Consistent with this, it has been reported that depletion of
survivin from erythroblasts causes defects in endosome/lysosomal
trafficking, which ultimately manifests as an increase in
autophagosomes and can be rescued by expression of vacuolin-1,
a protein that promotes endosome-lysosome fusion (Keerthivasan
et al., 2012). Survivin has also been shown to bind to HBXIP/
LAMTOR5 (Marusawa et al., 2003), a component of the ragulator
complex that activates mTOR on the lysosome surface (Bar-Peled
et al., 2012), and with clathrin (Keerthivasan et al., 2012) which is
included in the membrane of many intracellular vesicles (Royle,
2006) and is also known to regulate ALR (Rong et al., 2012).
We have shown that the inhibitory influence that survivin has on
autophagy is independent of its interaction with LC3, which proves
that not all LIR motifs and LC3 interactions are autophagy-relevant.
So, is there a non-canonical function to the survivin-LC3
interaction? LC3 was initially identified as a protein that interacts
with a microtubule-binding protein, and its interaction between a
neuronal Ca2+-sensor called ‘caldendrin’ appears to be related to
microtubule association (Seidenbecher et al., 2004; Mann and
Hammarback, 1994). It also binds to FYVE and coiled-coil (CC)
domain-containing protein 1 (FYCO1) to mediate microtubule plus-
end directed vesicle transport (Pankiv et al., 2010), so one
possibility may be that its liaison with LC3 relates to its influence
on microtubule dynamics (Rosa et al., 2006). We are currently
investigating this possibility.
Conclusions
In summary, the data herein presented show that survivin can
restrict excessive autophagy by reducing autophagic flux and
restricting autophagosome maturation. We also identify F61KEL
as a function LIR in the BIR domain of survivin, and show that its
Fig. 2. Survivin regulates autophagosome and lysosome size. (A) Representative images of U2OS cells transiently expressing survivin-RFP and LC3-
GFP treated with RAP (200 nM) and CQ (120 µM) for 2 h then imaged live. (B) Mean GFP-LC3 puncta size was measured using ImageJ, N>500 puncta, >35
cells over four independent experiments. (C) Live U2OS cells stably expressing GFP or survivin-GFP were stained with LysoTracker Red to highlight acidic
compartments. (D) Mean acidic puncta size was measured using ImageJ, N>1500 puncta for>30 cells for each condition in three independent experiments.
All error bars indicate s.e.m. ****P<0.0001.
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Fig. 3. See next page for legend.
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inhibition of excessive autophagy is independent of its interaction
with LC3.
MATERIALS AND METHODS
Unless otherwise stated all reagents were obtained from Sigma-Aldrich.
Cell culture
Human osteosarcoma cells and human embryonic kidney (HEK 293T) cells
were cultured at 37°C, with 5% CO2 in Dulbecco’s Modified Eagle’s
Medium (DMEM D6429) supplemented with 10% FCS (Hyclone; PAA
Labs). U2OS cells stably expressing GFP or survivin-GFP cells were
generated as described in (Jin et al., 2015) and medium supplemented with
50 µg/ml G418 (Geneticin) to maintain expression. Transient transfections
were performed using Torpedo transfection reagent (Ibidi) using DNA
diluted in PBS as per manufacturer’s instructions.
Plasmid constructs
RFP (pDsRed1), survivin-RFP (pDsRed1, survivin insert),
survivinF61AL64A-RFP (pDsRed1, survivinF61AL64A insert), flag
(pcDNA3.1, flag insert), flag-survivin (pcDNA3.1, flag-survivin insert),
flag-survivinF61AL64A (pcDNA3.1, flag-survivinF61AL64A insert),
GFP (pcDNA3.1, GFP insert), survivin-GFP (pcDNA3.1, survivin-GFP
insert), survivinF61AL64A-GFP (pcDNA3.1 survivinF61AL64A-GFP),
GFP-LC3 (pEGFP-N1, LC3 insert).
Drug treatments
To induce autophagy cells were treated for 2 h at 37°C with 200 nM RAP
(PHZ1235; Thermo Fisher Scientific). Working stocks of 200 µM
lyophilized RAP dissolved in DMSO were stored in aliquots at −20°C.
To inhibit autophagic flux, cells were treated with 120 µM CQ (C6628;
Sigma-Aldrich) for 2 h at 37°C or 50 µM CQ for >2 h incubation. Working
stocks of 100 mM CQ diphosphate salt dissolved in water were stored in
aliquots at −20°C.
Immunoblotting
Standard procedures were used for SDS-PAGE and transfer to PVDF
(Amersham Hybond 0.2 µm; GE Healthcare) membrane. Membranes were
blocked in 5% (w/v) milk in PBS with 0.1% (w/v) Tween-20. The following
primary antibodies were diluted in blocking solution and used to
immunoprobe membranes: anti-LC3, which recognises LC3A and LC3B
(1:2000; Sigma-Aldrich, L8918), anti-tubulin (1:2000; Sigma-Aldrich,
T5168), anti-GFP (1:2000; Sigma-Aldrich, G1546), anti-survivin (1:1000;
Novus, NB500-201), anti-histone H3 pT3 (1:2000; 159 Novus, NBP2-
61546), anti-p62 (1:1000; Enzo Life Sciences, BML-PW9860). Horse-
radish peroxidise-conjugated secondary antibodies (1:2000; Dako) were
diluted in either PBS with 0.1% tween (anti-survivin) or blocking medium
(all others) and signals detected using enhanced chemiluminescence
(Amersham ECL; GE Healthcare) and X-ray film (Amersham Hyperfilm;
GE Healthcare). ImageJ (Schneider et al., 2012) was used for quantification.
Fluorescence imaging
Cells were seeded onto 8-well IbiTreat chambered MicroSlides (Ibidi),
incubated overnight, then transfected with relevant DNA constructs, and
incubated for 24 h. Medium was replaced with HEPES buffered phenol red
free DMEM with 10% FCS supplemented with 200 nM RAP, 120 µm CQ
or 0.04 nM LysoTracker Red (L7528; Thermo Fisher Scientific) where
applicable. Cells were imaged on an inverted fluorescence microscope
(Olympus Delta Vision Elite) using oil immersion objectives: 60× (NA
1.42), or 100× (NA 1.40). Z-stacks were taken at 0.3 µm intervals,
deconvolved and z-projected for maximum intensity using SoftWorx
software (Applied Precision). Bespoke macros were used with ImageJ
(Schneider et al., 2012) software to count and measure puncta.
Immunoprecipitations
HEK293T cells were used for all co-immunoprecipitation experiments. For
immunoprecipitation of survivin, cells were seeded onto a 6-well plate and
once approximately 70% confluent, transfected with plasmid constructs for
GFP-LC3 and either Flag (control), Flag-Survivin or Flag-survivinF61A,L64A.
After 24 h, cells were washed with cold PBS and harvested by scraping into
ice-cold lysis buffer (50 mM TrisHCl pH 7.5, 150 mMNaCl, 1 mM EDTA,
1% Triton x-100, 1 µg/ml CLAP containing chymostatin, leupeptin,
antipain, pepstatin A and 100 µM AEBSF) and lysed on ice (30 min) with
gentle pipetting. Lysates were clarified by centrifugation at 17,000 g to
eliminate cell debris and DNA (10 min at 4°C) and the supernatant retained.
A sample of the lysate (20 µl) was removed as an input sample and boiled in
20 µl sample buffer (125 mM TrisHCl, pH 6.8, 4% SDS, 20% glycerol,
0.004% bromophenol blue) in a heat block at 90°C for 3 min. To the
remainder, Anti-flagM2Affinity Gel (A2220; Sigma-Aldrich) was added to
precipitate flag-tagged proteins as per the recommended protocol.
For immunoprecipitation of LC3, cells were seeded on a six-well plate
and grown to 70% confluence, then transfected with plasmid constructs for
survivin or survivinF61AL64A, and either GFP (control) or GFP-LC3. After
24 h, cells were harvested and re-plated into 10 cm2 tissue culture dishes.
Once 70% confluent, cells were scraped into 1 ml cold PBS and washed
twice by centrifugation at 500× g. Each cell pellet was then resuspended in
200 µl lysis buffer (10 mM Tris/Cl pH 7.5; 150 mM NaCl; 0.5 mM EDTA;
0.5% NP-40, 1 µg/ml CLAP containing chymostatin, leupeptin, antipain
and pepstatin A, 100 µM AEBSF) and lysed on ice for 30 min with gentle
pipetting. DNA and cell debris were pelleted as above and supernatant
retained. GFP-Trap-A beads (gta20; ChromoTek) were used to precipitate
GFP and GFP-tagged proteins as per the manufacturer’s protocol.
Statistical methods
Data from fluorescence images were analysed using GraphPad Prism where
paired immunoblots or unpaired two-tailed t-tests were performed to
compare the data between conditions, and Welch’s correction where
sample variance was considered significant by an f-test. A P<0.05 for the
t-test or f-test was considered significant. Outliers were removed from all
fluorescence imaging measurements using the GraphPad ROUT method.
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Fig. 3. Survivin F61KEL is a canonical LIR but is not required for
autophagy inhibition. (A) The primary sequence of survivin contains five
putative LIR motifs, underscored in black within this sequence logo
(Schneider and Stephens, 1990) generated from several mammalian
homologues of survivin using WebLogo (http://weblogo.berkeley.edu). One
stack represents a single position in the sequence, stack height indicates the
sequence conservation, and the height of each symbol in the stack indicates
the relative frequency of each amino acid at that position. (B) Location of the
five putative LIR sites (blue) within the tertiary structure of survivin [PDB 1E31,
graphic produced using UCSF Chimera, San Francisco (Pettersen et al.,
2004)]. Only F61KEL overlaps a beta strand (blue ribbon). (C) HEK293T cells
expressing GFP-LC3 were transiently transfected with either Flag, Flag-
survivinWT or Flag-survivinF61A,L64A. Lysates were immunoprecipitated with
anti-Flag antibodies and analysed by immunoblotting for survivin and LC3,
N=2. (D) HEK293T cells expressing GFP or GFP-LC3 were transiently
transfected with survivinWT or survivinF61A,L64A. Lysates were
immunoprecipitated with anti-GFP antibodies and analysed by immunoblotting
for survivin and GFP. (E) U2OS cells transiently expressing RFP, survivinWT-
RFP or survivinF61A,L64A-RFP and LC3-GFP were treated with RAP (200 nM)
and CQ (120 µM) for 2 h prior to live cell imaging. Average GFP-LC3 puncta
size was measured using ImageJ for each condition N>500 puncta over three
independent experiments. (F) Living U2OS cells expressing GFP, survivin-
GFP or survivinF61A,L64A-GFP were stained with LysoTracker Red to highlight
acidic compartments and CQ (120 µM) for 2 h, then imaged live. Average size
of acidic puncta was measured using ImageJ for each condition, n>1400
puncta. All experiments representative of N=3. Error bars indicate s.e.m.
****P<0.0001.
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